Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.7453 per EA under NDC 59651008818. Its NADAC has been published 138 times since Nov 8, 2023.
Strength
800 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651008818
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212599On Market Since
7/11/2023
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 138 times since Nov 8, 2023, and over the history we have for it it has declined 68.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7453 per EA |
|---|---|
| All-time high | $2.3333 (Nov 15, 2023) |
| All-time low | $0.7453 (Jun 17, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7453 |
| Median price | $1.3473 |
| Average price | $1.3785 |
| Largest weekly change | -37.7% (May 22, 2024) |
| Weeks tracked | 138 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the SEVELAMER HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.7453 per EA (NDC 59651008818), effective Jun 24, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 68.1%. It has been tracked across 138 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Nov 8, 2023, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7453 (Jun 17, 2026) to a high of $2.3333 (Nov 15, 2023), with a median of $1.3473 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SEVELAMER HCL 800 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 59651008818) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification